首站-论文投稿智能助手
典型文献
Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
文献摘要:
Utilization of the intestinal lymphatic pathway will allow extraordinary gains in lymph and tumors cascade-targeted delivery of oral drugs and awakening the innate/adaptive immunity of the body and the lesion microenvironment,in addition to improving oral bioavailability relative to other means of delivery of oral drugs.Here,inspired by the specific invasion route of intestinal microorganisms,we pio-neered an immune-awakening Saccharomyces-inspired mesoporous silicon nanoparticle(yMSN)for the ingenious cascade-targeted delivery of therapeutic cancer vaccines and antitumor drugs to lymph and tu-mors via the intestinal lymphatic pathway.Encouragingly,yMSN high-loaded tumor-specific antigens(OVA,11.9%)and anti-tumor drugs(Len,28.6%)with high stability,namely Len/OVA/yMSN,efficiently co-delivered OVA and Len to their desired target sites.Moreover,yMSN concomitantly awakened the innate antitumor immunity of dendritic cells and macrophages,strengthening vaccine-induced adaptive immune responses and reversing macrophage-associated immunosuppression in the tumor microenviron-ment.Surprisingly,Len/OVA/yMSN treatment resulted in excellent synergistic antitumor efficacy and long-term antitumor memory in OVA-Hepa1-6-bearing mice.This high-performance nanocarrier pro-vides a novel approach for lesion-targeting delivery of oral drugs accompanied with awakening of the innate/adaptive immunity of the lesion environment,and also represents a novel path for the oral delivery of diverse therapeutic agents targeting other lymph-mediated diseases.
文献关键词:
作者姓名:
Yuling Mao;Xiudan Wang;Caishun Chen;Qinfu Zhao;Yanfeng Liu;Jinghai Zhang;Siling Wang
作者机构:
Department of Pharmaceutics,School of Pharmacy,Shenyang Pharmaceutical University,Shenyang 110016,China;School of Life Science and Bio-pharmaceutics,Shenyang Pharmaceutical University,Shenyang 110016,China;Department of Biomedical Engineering,School of Medical Devices,Shenyang Pharmaceutical University,Shenyang 110016,China
引用格式:
[1]Yuling Mao;Xiudan Wang;Caishun Chen;Qinfu Zhao;Yanfeng Liu;Jinghai Zhang;Siling Wang-.Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors)[J].药学学报(英文版),2022(12):4501-4518
A类:
pio,yMSN,mors,awakened
B类:
Immune,awakening,Saccharomyces,inspired,nanocarrier,oral,delivery,tumors,Utilization,intestinal,lymphatic,pathway,will,allow,extraordinary,gains,cascade,targeted,drugs,innate,adaptive,immunity,body,lesion,microenvironment,addition,improving,bioavailability,relative,other,means,Here,by,specific,invasion,route,microorganisms,we,neered,immune,mesoporous,silicon,nanoparticle,ingenious,therapeutic,cancer,vaccines,antitumor,via,Encouragingly,high,loaded,antigens,OVA,Len,stability,namely,efficiently,delivered,their,desired,sites,Moreover,concomitantly,dendritic,cells,macrophages,strengthening,induced,responses,reversing,associated,immunosuppression,Surprisingly,treatment,resulted,excellent,synergistic,efficacy,long,term,memory,Hepa1,bearing,mice,This,performance,vides,novel,approach,targeting,accompanied,also,represents,diverse,agents,mediated,diseases
AB值:
0.468335
相似文献
Targeting the Rac1 pathway for improved prostate cancer therapy using polymeric nanoparticles to deliver of NSC23766
Zean Li;Jun Huang;Tao Du;Yiming Lai;Kaiwen Li;Man-Li Luo;Dingjun Zhu;Jun Wu;Hai Huang-Department of Urology,Sun Yat-sen Memorial Hospital,Sun Yat-sen University,Guangzhou 510220,China;Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation,Sun Yat-sen Memorial Hospital,Sun Yat-sen University,Guangzhou 510120,China;Medical Research Center,Sun Yat-sen Memorial Hospital,Sun Yat-sen University,Guangzhou 510120,China;School of Biomedical Engineering,Sun Yat-sen University,Shenzhen 518107,China;Department of Obstetrics and Gynecology,Sun Yat-sen Memorial Hospital,Sun Yat-sen University,Guangzhou 510120,China;Department of Urology,The Sixth Affiliated Hospital of Guangzhou Medical University,Qingyuan People's Hospital,Qingyuan 511518,China
Nanoparticles targeting at methylases with high correlation to N6-methyladenosine-related lncRNA signatures as potential therapy of kidney clear cell carcinoma
Ruixuan Chen;Ping Ouyang;Licong Su;Xi Xu;Penghu Lian;Yanqin Li;Qi Gao;Yifan Zhang;Sheng Nie;Fan Luo;Ruqi Xu;Xiaodong Zhang;Xiaoxi Li;Yue Cao;Peiyan Gao;Juanjuan Kang;Jun Wu;Lu Li-National Clinical Research Center for Kidney Disease,State Key Laboratory of Organ Failure Research,Guangdong Provincial Clinical Research Center for Kidney Disease,Nanfang Hospital,Southern Medical University,Guangzhou 510000,China;Department of Health Management,Nanfang Hospital,Southern Medical University,Guangzhou 510000,China;Department of Hematology,Nanfang Hospital,Southern Medical University,Guangzhou 510000,China;Department of Urology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College(CAMS&PUMC),Beijing 100730,China;Department of Urology,Nanfang Hospital,Southern Medical University,Guangzhou 510000,China;Affiliated Foshan Maternity&Child Healthcare Hospital,Southern Medical University,Foshan 528000,China;School of Biomedical Engineering,Sun Yat-sen University,Shenzhen 518107,China;Department of Radiation Oncology,Nanfang Hospital,Southern Medical University,Guangzhou 510000,China
Defined tumor antigen-specific T cells potentiate personalized TCR-T cell therapy and prediction of immunotherapy response
Jingjing He;Xinxin Xiong;Han Yang;Dandan Li;Xuefei Liu;Shuo Li;Shuangye Liao;Siyu Chen;Xizhi Wen;Kuai Yu;Lingyi Fu;Xingjun Dong;Kaiyu Zhu;Xiaojun Xia;Tiebang Kang;Chaochao Bian;Xiang Li;Haiping Liu;Peirong Ding;Xiaoshi Zhang;Zhenjiang Liu;Wende Li;Zhixiang Zuo;Penghui Zhou-State Key Laboratory of Oncology in Southern China,Collaborative Innovation Center for Cancer Medicine,Sun Yat-sen University Cancer Center,Guangzhou,China;Guangdong Provincial People's Hospital,Guangdong Academy of Medical Sciences,Guangzhou,China;Guangdong Laboratory Animals Monitoring Institute,Guangdong Key Laboratory of Laboratory Animals,Guangzhou,China;Guangzhou Finelmmune Biotechnology Co.,LTD,Guangzhou,China
Intercellular transfer of activated STING triggered by RAB22A-mediated non-canonical autophagy promotes antitumor immunity
Ying Gao;Xueping Zheng;Boyang Chang;Yujie Lin;Xiaodan Huang;Wen Wang;Shirong Ding;Weixiang Zhan;Shang Wang;Beibei Xiao;Lanqing Huo;Youhui Yu;Yilin Chen;Run Gong;Yuanzhong Wu;Ruhua Zhang;Li Zhong;Xin Wang;Qiuyan Chen;Song GaoHu;Zhengfan Jiang;Denghui Wei;Tiebang Kang-Sun Yat-sen University Cancer Center,State Key Laboratory of Oncology in South China,Collaborative Innovation Center for Cancer Medicine,Guangzhou,Guangdong,China;Department of Interventional Radiology,The Third Affiliated Hospital of Sun Yat-sen University,Guangzhou,Guangdong,China;Department of Abdominal Oncology,The Cancer Center of the Fifth Affiliated Hospital of Sun Yat-sen University,Zhuhai,Guangdong,China;Key Laboratory of Cell Proliferation and Differentiation of the Ministry of Education,School of Life Sciences,Peking University,Beijing,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。